This legislation targets the proliferation of highly potent kratom-derived compounds — specifically 7-hydroxymitragynine and mitragynine pseudoindoxyl — that have been sold in convenience stores, gas stations, and similar retail outlets, often marketed as legal alternatives to opioids. The bill's central objective is to draw a sharp regulatory distinction between naturally occurring trace concentrations of these alkaloids in raw or minimally processed kratom products and the synthetically enhanced, concentrated, or chemically converted forms that pose significantly greater abuse and addiction potential. By establishing precise concentration thresholds and conditioning a statutory exemption on compliance with those thresholds, the bill seeks to bring the most dangerous kratom-derived products under the scheduling authority of the Controlled Substances Act while preserving access to traditional kratom products that remain within natural concentration limits. The legislation reflects a targeted public health response to a documented pattern of manufacturers artificially boosting the potency of kratom extracts to levels that mimic the pharmacological profile of opioids.

What is the status of S5383?

Introduced as of August 8, 2026.

This legislation targets the proliferation of highly potent kratom-derived compounds — specifically 7-hydroxymitragynine and mitragynine pseudoindoxyl — that have been sold in convenience stores, gas stations, and similar retail outlets, often marketed as legal alternatives to opioids. The bill's central objective is to draw a sharp regulatory distinction between naturally occurring trace concentrations of these alkaloids in raw or minimally processed kratom products and the synthetically enhanced, concentrated, or chemically converted forms that pose significantly greater abuse and addiction potential. By establishing precise concentration thresholds and conditioning a statutory exemption on compliance with those thresholds, the bill seeks to bring the most dangerous kratom-derived products under the scheduling authority of the Controlled Substances Act while preserving access to traditional kratom products that remain within natural concentration limits. The legislation reflects a targeted public health response to a documented pattern of manufacturers artificially boosting the potency of kratom extracts to levels that mimic the pharmacological profile of opioids.

What is the status of S5383?

Introduced as of August 8, 2026.

S5383 U.S. Senate: End Gas Station Heroin Act

Introduced

S. 5383

Introduced in Senate · August 28, 2026

August 8 (

legislative day

, August 7), 2026

Mr. Moreno introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To amend the Controlled Substances Act to schedule MGM–15 and MGM–16 as Schedule I Controlled substances, and to amend the controlled Substances Act to schedule synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl, as a Schedule I above a specific threshold under the Controlled Substances Act, and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids, commonly known as gas station heroin.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “End Gas Station Heroin Act”.

Introduced

S. 5383

Introduced in Senate · August 28, 2026

August 8 (

legislative day

, August 7), 2026

Mr. Moreno introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “End Gas Station Heroin Act”.

Introduced

S. 5383

Introduced in Senate · August 28, 2026

August 8 (

legislative day

, August 7), 2026

Mr. Moreno introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “End Gas Station Heroin Act”.

Introduced

S. 5383

Introduced in Senate · August 28, 2026

August 8 (

legislative day

, August 7), 2026

Mr. Moreno introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “End Gas Station Heroin Act”.

S.5383

S. 5383

S.5383

S. 5383

S.5383

S. 5383

S.5383

S. 5383